Biohaven (NYSE:BHVN) and Yale University announced a favorable verdict from a federal jury in the U.S. District Court for the District of Delaware regarding their ongoing litigation against Avilar Therapeutics and RA Capital.
Bank of Hawai‘i (NYSE:BOH) reported second-quarter net income of $63.8 million, up 11.1% sequentially, with diluted EPS of $1.47.
Kura Oncology (NASDAQ:KURA) reported 33%–50% response rates for darlifarnib plus cabozantinib among 34 evaluable advanced kidney-cancer patients.
Perfect Corp. (NYSE:PERF) reported second-quarter net income of $1.3 million, up 518.4%, while revenue remained stable at $16.3 million.
Legend Biotech (NASDAQ:LEGN) announced a significant leadership transition, confirming that Ying Huang, Ph.D., has stepped down from his role as Chief Executive Officer and as a member of the Board of Directors, effective July 24, 2026.
The Ensign Group (NASDAQ:ENSG) reported second-quarter revenue of $1.44 billion, up 17.3%, as occupancy and skilled-care revenue increased.
Rocket Lab (NASDAQ:RKLB) won a $266 million Space Force contract covering 12 suborbital vehicles and six optional launches.
IDEAYA Biosciences (NASDAQ:IDYA) announced the initiation of the Part 2 monotherapy expansion for its Phase 1/2 clinical trial evaluating IDE892.
AstraZeneca (NYSE:AZN) reported second-quarter core EPS of $2.63, up 21%, as oncology and rare-disease sales grew.
Japanese regulators are considering increasing the leverage limits available for cryptocurrency trading as part of a broader review of the country's digital asset rules.
GET YOUR GRAFA EDGE NOW
We'll switch on a 30-day Edge trial as a welcome gift
